Previous 10 | Next 10 |
Thinly traded micro cap Immunic (NASDAQ: IMUX ) slips 13% premarket on average volume in reaction to its direct sale of ~1.8M common shares at $8.50 per share to certain institutional investors. More news on: Immunic, Inc., Healthcare stocks news, Stocks on the move, , Re...
NEW YORK , April 23, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that it has entered into securit...
COVID-19 Penny Stocks Have Been Soaring & These Are 3 That Made It Big So Far Most coronavirus news focuses on bad things like new cases, deaths, and the overall spread. However, there are high points investors are paying attention to. With news last week of Gilead’s ( GILD Stock Re...
Gainers: SAExploration (NASDAQ: SAEX ) +91% . More news on: SAExploration Holdings, Inc., The Peck Company Holdings, Inc., Delek Logistics Partners, LP, Stocks on the move, , Read more ...
SAExploration Holdings (NASDAQ: SAEX ) +177% on $27M new project in Greece. More news on: SAExploration Holdings, Inc., B.O.S. Better Online Solutions Ltd., The Peck Company Holdings, Inc., Stocks on the move, Read more ...
Ultra-thinly traded nano cap Immunic (NASDAQ: IMUX ) jumps 16% after hours on the heels of its announcement that lead candidate IMU-838 has demonstrated activity against SARS-CoV-2 in preclinical testing. More news on: Immunic, Inc., Healthcare stocks news, Stocks on the move...
NEW YORK , April 21, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today reported that its lead asset, IM...
NEW YORK , April 17, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced a series of changes to its Execu...
Gainers: Astrotech (NASDAQ: ASTC ) +425% . More news on: Astrotech Corporation, T2 Biosystems, Inc., BroadVision, Inc., Stocks on the move, , Read more ...
Immunic (NASDAQ: IMUX ): FY GAAP EPS of -$4.52. More news on: Immunic, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Immunic Inc. Company Name:
IMUX Stock Symbol:
NYSE Market:
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. Muehler explained that IBD encompasses Crohn's disease and ulcerative colitis, characterised ...
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease and the company’s developments in treating it. Kohlhof explai...
--News Direct-- Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseas...